4 European Projects Found
Searched on 125080 European Projects
FINISHED
Bringing the artificial pancreas home (AP@home)
Start date: Feb 1, 2010, End date: Oct 31, 2014,
Description
In order to improve treatment of diabetes patients at home, the main goal of AP@Home is to build and evaluate an artificial pancreas (AP). The AP will allow automated glucose control: It monitors your blood glucose (sugar) levels and a software algorithm calculates how much insulin to deliver at any time via a built-in insulin in ...
Read Project
15
Partners Participants
FINISHED
Personal Glucose Predictive Diabetes Advisor (DIAdvisor)
Start date: Mar 1, 2008, End date: Jun 30, 2012,
The DIAdvisor is a large scale integrating project (IP) aiming at development of a prediction based tool which uses past and easily available information to optimise the therapy of type I and developed type II diabetes.The DIAdvisor does not depend on specific sensor technologies and technologies like standard strip sensing, minimally-invasive continuous glucose sensors and non-invasive methods.Fo ...
Read Project
13
Partners Participants
FINISHED
Mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics (Mitotarget)
Start date: Feb 1, 2009, End date: Mar 31, 2012,
Mitochondrial dysfunction is a major hallmark of various neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, Huntington’s diseases or Amyotrophic Lateral Sclerosis (ALS). However linking mitochondrial dysfunction to the pathogenesis of some of these diseases still needs to be elucidated. Furthermore, in pathologies where this link is already established, the question re ...
Read Project
19
Partners Participants
FINISHED
Natural course, pathophysiology, models for early diagnosis, prevention and innovative treatment of TNF Receptor Associated Periodic Syndrome TRAPS with application for all hereditary recurrent fevers (EUROTRAPS)
Start date: Apr 1, 2008, End date: Sep 30, 2011,
The TNF Receptor Associated Syndrome (TRAPS) is a rare disease of innate immunity, caused by mutations in TNFR1. It is characterised by recurrent bouts of fever and pain and mainly affects patients of European ancestry. The development of renal amyloidosis in up to 20% of cases makes it a potentially fatal disease. Corticosteroids and anti-TNF therapeutics have not been consistently effective in c ...
Read Project
